日本語 
Français 
Biotherapies: Attonuclei has developed a quantum biomolecule to revolutionise Covid testing
Attonuclei, a specialist in quantum dots, has invested €3.5 million over two years in a…
January 13, 2023
Healthcare: Atlantic France’s leading cancer center ICO joins the TriNetX global health research network
L’Institut de Cancérologie de l’Ouest located in the Atlantic France region has joined the global…
December 28, 2021
Healthcare: biotech cluster Atlanpole Biotherapies working to build French sovereignty
Located in Atlantic France, Atlanpole Biotherapies is one of the most attractive and dynamic clusters…
December 14, 2021
Healthcare: a €13 million investment for biopharmaceutical company Clean Cells
The biotech Clean Cells is building a new 5,300 sqm site in Montaigu, Atlantic France….
December 2, 2021
Biotech: Xenothera signs a contract for a pre-order of 30,000 doses of a Covid-19 treatment with the French government
The Nantes-based biotech Xenothera has developed the XAV-19. This polyclonal antibody is effective against SARS-CoV-2,…
August 23, 2021
Biotech: Ose immunotherapeutics signs worldwide licensing agreement in organ transplantation
The company from Nantes OSE Immunotherapeutics has signed a contract with Veloxis Pharmaceuticals to grant…
July 15, 2021
3 innovative biotech companies in Atlantic France
On February 11th, we co-organised a webinar on health and biotechnology in Atlantic France with…
March 22, 2021
The biotech company Eurofins launches key SARS-CoV-2 detection solutions
Eurofins developed several innovations to fight the Covid-19 pandemic. Over the last weeks, the company…
January 18, 2021
AlgoSource: microalgae against the side effects of anti-cancer treatments
The company from Saint-Nazaire AlgoSource is developing an innovative solution based on microalgae. Its purpose…
July 13, 2020